Keyphrases
Mantle Cell Lymphoma
100%
Ibrutinib
34%
Lymphoma Cells
25%
NF-B
22%
Epidermal Growth Factor Receptor
19%
Tumor Progression
18%
Venetoclax
18%
Overcoming Resistance
18%
CARMA3
17%
Lymphoma Patients
16%
Bruton's Tyrosine Kinase
16%
Cyclin-dependent Kinase 9 (CDK9)
16%
Nuclear factor-κB
16%
Bruton Tyrosine Kinase Inhibitor
14%
Chemotherapy Resistance
12%
Ibrutinib Resistance
12%
Chimeric Antigen Receptor T Cells (CAR-T)
10%
Signal Component
10%
Co-target
9%
MALT1
9%
Apoptosis Repressor with Caspase Recruitment Domain
9%
Phosphoinositide 3-kinase (PI3K)
9%
Chimeric Antigen Receptor T-cell Therapy
8%
Inflammatory Response
8%
B-cell Lymphoma 2 (Bcl-2)
8%
Cell Adhesion
8%
Apoptosis
8%
Lethality
8%
Mycobiota
8%
Glutaminase 1 (GLS1)
8%
B-cell Receptor Signaling
8%
Arrhythmogenic Right Ventricular Dysplasia
8%
Transmembrane Protein 43
8%
TMEM43
8%
Innate Immunity
8%
High Risk
8%
Tumor-immune System
8%
Receptor 1
8%
Outcome Profiles
8%
Dual Inhibition
8%
Rac2
8%
Potentiation
8%
Nuclear factor-B
8%
Viral Infection
8%
Antagonistic Antibody
8%
Inhibitor of Apoptosis Proteins
8%
Anticancer Activity
8%
Induced Activation
8%
Heat Shock Protein 90 (Hsp90)
8%
Multidrug-resistant
8%
Medicine and Dentistry
Mantle Cell Lymphoma
96%
Ibrutinib
38%
Bruton Tyrosine Kinase
23%
Mantle Cell Lymphoma Cell
20%
Chimeric Antigen Receptor T-Cell Immunotherapy
20%
Programmed Cell Death
18%
Venetoclax
16%
Cyclin-Dependent Kinase 9
16%
Neoplasm
15%
Chimeric Antigen Receptor T-Cell
14%
Bruton Tyrosine Kinase Inhibitor
11%
Chimeric Antigen Receptor
10%
Mantle Cell Lymphoma Cell Line
9%
Cell Adhesion
9%
Lethality
9%
Antineoplastic Activity
9%
Receptor
9%
Xenograft
8%
Glutaminase
8%
B Lymphocyte Receptor
8%
Protein Kinase B
8%
Inhibitor of Apoptosis Protein
8%
Cancer
8%
Protein Kinase B Inhibitor
8%
Mycosis
8%
Innate Immunity
8%
T Cell
8%
Cancer Therapy
8%
Downregulation
8%
Deacetylation
8%
Antibody-Drug Conjugate
8%
Tumor Cell
8%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
8%
Histone
8%
In Vitro
7%
Cell Signaling Pathway
6%
Lectin Receptor
5%
IC50
5%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
33%
Bruton Tyrosine Kinase
29%
Cyclin-Dependent Kinase 9
24%
Tumor Progression
22%
Ibrutinib
22%
T Cell
20%
Genomics
16%
Chimeric Antigen Receptor
16%
Tyrosine Kinase Inhibitor
12%
SMARCA4
10%
Immunity
10%
Innate Immunity
10%
Glutaminase
8%
MALT1
8%
TMEM43
8%
DNA Binding
8%
Membrane Protein
8%
Transmembrane Protein
8%
Endoplasmic Reticulum Stress
8%
Complement Factor B
8%
Mucosa
8%
BCL10
8%
Immunoglobulin Enhancer Binding Protein
8%
Herpes Simplex Virus
8%
DNA Synthesis
8%
Histone
8%
Epidermal Growth Factor
8%
CD23
8%
Deacetylation
8%
Rituximab
8%
Arginine
8%
Dysplasia
8%
Exome Sequencing
6%
Cancer Cell
6%
CD19
6%
IC50
6%
Programmed Cell Death
6%
Immunocompetent Cell
6%
Drug Resistance
6%
Cell Survival
5%
Polymerase
5%
